Dianthus Therapeutics (DNTH) Operating Margin (QoQ) (2022 - 2025)

Dianthus Therapeutics (DNTH) Operating Margin (QoQ) (2022 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn
7 Belite Bio 61.40 Bn 61.40 Bn -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn
9 Revolution Medicines 37.37 Bn 37.37 Bn -
10 Dianthus Therapeutics 3.92 Bn 3.51 Bn -

Historic Data

Download Data
DateValue
Sep 30, 2025 792,315.00
Jun 30, 2025 -1.53 Mn
Mar 31, 2025 -35,781.00
Dec 31, 2024 -103,033.00
Sep 30, 2024 -18,477.00
Jun 30, 2024 84,981.00
Mar 31, 2024 79,336.00
Dec 31, 2023 -112,949.00
Sep 30, 2023 -49,025.00
Jun 30, 2023 39,880.00
Mar 31, 2023 -70,403.00
Dec 31, 2022 -20,638.00